Results 21 to 30 of about 161,421 (304)
Perspectives on Medical Education, 2018 Background Online educational resources are criticized as being teacher-centred, failing to address learner’s needs. Needs assessments are an important precursor to inform curriculum development, but these are often overlooked or skipped by developers of
Teresa M. Chan +8 more
doaj +1 more source
Thromboembolic complications in COVID-19 disease, a brief update
Вестник анестезиологии и реаниматологии, 2021 The role of coagulopathy in severe novel coronavirus infection remains to be clarified. Coagulopathy mechanisms can be summarised in two main pathways: inflammation-related and specific-virus related pathways.
А. Lavrentieva, S. Tsotsolis
doaj +1 more source
Epidemiology and pathophysiology of cancer-associated thrombosis [PDF]
, 2010 Venous thromboembolism (VTE) is a common complication in patients with malignant disease. First recognised by Bouillard in 1823 and later described by Trousseau in 1844, multiple studies have since provided considerable evidence for a clinical ...
Pasi, J +5 more
core +1 more source
Omalizumab as a Provoking Factor for Venous Thromboembolism
Drug Target Insights, 2019 A 43-year-old man with a history of severe extrinsic allergic asthma treated with once-monthly omalizumab (600 mg) for the last 15 months. He presented to the emergency room with a 2-week history of right lower limb pain and chest pleuritic pain ...
Crhistian-Mario Oblitas +4 more
doaj +1 more source
Direct Oral Anticoagulants for the Treatment of Unusual-Site Venous Thrombosis: An Update
PharmaceuticsDirect oral anticoagulants (DOACs) have emerged as the preferred oral anticoagulant therapy for patients with deep vein thrombosis of the lower extremities and pulmonary embolism. DOACs offer several advantages over vitamin K antagonists, including fixed
Anabel Franco-Moreno +4 more
doaj +1 more source
Proteus Syndrome: A Rare Case in An Adult Ward
European Journal of Case Reports in Internal Medicine, 2021 Proteus syndrome is an extremely rare disorder that manifests as an asymmetric, disproportionate overgrowth of any connective tissue, such as bone, fat or epidermal nevi, in a mosaic or patchy pattern.
Catarina Duarte Santos +6 more
doaj +1 more source
Cancer and thrombosis: Managing the risks and approaches to thromboprophylaxis [PDF]
, 2006 Patients with cancer are at increased risk of venous thromboembolism (VTE) compared with patients without cancer. This results from both the prothrombotic effects of the cancer itself and iatrogenic factors, such as chemotherapy, radiotherapy, indwelling
Erhard Hiller, Hiller, Erhard
core +1 more source
Research and Practice in Thrombosis and Haemostasis, 2020 Background The COVID‐19 pandemic has focused medical attention on treating affected patients and protecting others from infection. However, concerns have been raised regarding the pandemic´s impact and associated containment measures (eg curfew, lockdown)
Stephan Nopp +6 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Background Blood pressure (BP) variability has reportedly been a risk factor for various clinical events. To clarify the influence of BP visit‐to‐visit variability on adverse events in patients with nonvalvular atrial fibrillation, a post hoc analysis of
Eitaro Kodani +6 more
doaj +1 more source
Simple measures can improve care in our hospitals : an audit of venous thromboembolism practice [PDF]
, 2013 : Venous thromboembolism (VTE) is a serious but preventable complication of hospitalisation. Doctors still sometimes fail to adhere to them, thus putting patients at risk and incurring considerable expense for the national health service.
Azzopardi, Stephanie +3 more
core